The Enterprise Value as of September 2024 (TTM) for Compugen Ltd. (CGEN) is 164.40M

According to Compugen Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 164.40M. This represents a change of 30.83% compared to the average of 125.67M of the last 4 quarters.

Compugen Ltd. (CGEN) Historical Enterprise Value (quarterly & annually)

How has CGEN Enterprise Value performed in the past?

The mean historical Enterprise Value of Compugen Ltd. over the last ten years is 281.74M. The current 164.40M Enterprise Value has changed 5.74% with respect to the historical average. Over the past ten years (40 quarters), CGEN's Enterprise Value was at its highest in in the September 2020 quarter at 1.22B. The Enterprise Value was at its lowest in in the September 2023 quarter at 35.76M.

Compugen Ltd. (CGEN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Compugen Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compugen Ltd. (CGEN) Average Enterprise Value

How has CGEN Enterprise Value performed in the past?

The current Enterprise Value of Compugen Ltd. (CGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Compugen Ltd. (CGEN) Enterprise Value vs. Peers

How is CGEN’s Enterprise Value compared to its peers?

Compugen Ltd.’s Enterprise Value is greater than BiomX Inc. (-5188847.00), greater than Pluri Inc. (51.04M), greater than Surface Oncology, Inc. (59.73M), greater than BioLineRx Ltd. (78.24M), less than iTeos Therapeutics, Inc. (191.40M), less than Icosavax, Inc. (713.87M), less than Mirati Therapeutics, Inc. (3.91B), less than VectivBio Holding AG (848.58M), less than Annexon, Inc. (621.99M), less than Allogene Therapeutics, Inc. (498.60M), less than Beam Therapeutics Inc. (2.00B), less than Sana Biotechnology, Inc. (944.18M), less than Caribou Biosciences, Inc. (172.45M), less than Editas Medicine, Inc. (289.73M), less than Can-Fite BioPharma Ltd. (0), greater than ImmuCell Corporation (8.92M), greater than Evogene Ltd. (42.56M), greater than CollPlant Biotechnologies Ltd. (5.14M), greater than null (41.50M),

Build a custom stock screener for Compugen Ltd. (CGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compugen Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compugen Ltd. (CGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compugen Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.